292 related articles for article (PubMed ID: 27144841)
1. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
2. Selective estrogen receptor modulators decrease invasiveness in pituitary adenoma cell lines AtT-20 and TtT/GF by affecting expression of MMP-14 and ADAM12.
Zhang Z; Bartsch JW; Benzel J; Lei T; Nimsky C; Voellger B
FEBS Open Bio; 2020 Nov; 10(11):2489-2498. PubMed ID: 33030286
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
[TBL] [Abstract][Full Text] [Related]
4. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
Liu W; Matsumoto Y; Okada M; Miyake K; Kunishio K; Kawai N; Tamiya T; Nagao S
J Med Invest; 2005 Aug; 52(3-4):151-8. PubMed ID: 16167532
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits pituitary adenoma cell viability, migration and invasion via ADAM12/EGFR signaling pathway.
Wang J; Zhang Z; Li R; Sun W; Chen J; Zhang H; Shu K; Lei T
Life Sci; 2018 Feb; 194():150-156. PubMed ID: 29288766
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-149 Regulates Proliferation, Migration, and Invasion of Pituitary Adenoma Cells by Targeting ADAM12 and MMP14.
Zhang Z; Schäfer A; Voellger B; Wang JW; Lei T; Nimsky C; Bartsch JW
Curr Med Sci; 2022 Dec; 42(6):1131-1139. PubMed ID: 36542326
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
Pan LX; Chen ZP; Liu YS; Zhao JH
J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
[TBL] [Abstract][Full Text] [Related]
9. CCNB1 affects cavernous sinus invasion in pituitary adenomas through the epithelial-mesenchymal transition.
Li B; Cheng J; Wang H; Zhao S; Zhu H; Li C; Zhang Y; Zhao P
J Transl Med; 2019 Oct; 17(1):336. PubMed ID: 31585531
[TBL] [Abstract][Full Text] [Related]
10. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
11. Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification.
Micko AS; Wöhrer A; Wolfsberger S; Knosp E
J Neurosurg; 2015 Apr; 122(4):803-11. PubMed ID: 25658782
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the growth rate and cavernous sinus invasion of pituitary adenomas.
Kawamoto H; Uozumi T; Kawamoto K; Arita K; Yano T; Hirohata T
Acta Neurochir (Wien); 1995; 136(1-2):37-43. PubMed ID: 8748825
[TBL] [Abstract][Full Text] [Related]
14. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
15. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
16. Expression of serine proteases and metalloproteinases in human pituitary adenomas and anterior pituitary lobe tissue.
Knappe UJ; Hagel C; Lisboa BW; Wilczak W; Lüdecke DK; Saeger W
Acta Neuropathol; 2003 Nov; 106(5):471-8. PubMed ID: 12904990
[TBL] [Abstract][Full Text] [Related]
17. MR imaging of cavernous sinus involvement by pituitary adenomas.
Scotti G; Yu CY; Dillon WP; Norman D; Colombo N; Newton TH; De Groot J; Wilson CB
AJR Am J Roentgenol; 1988 Oct; 151(4):799-806. PubMed ID: 3262283
[TBL] [Abstract][Full Text] [Related]
18. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas.
Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S
Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566
[TBL] [Abstract][Full Text] [Related]
20. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
